Anterix (ATEX) Insider Purchase: Scott Lang Acquires 4,650 Shares

Rhea-AI Filing Summary

Lang Scott A., President, CEO and Director of Anterix Inc. (ATEX), reported a personal purchase of company stock. On 09/18/2025 he acquired 4,650 shares of Common Stock at $21.28 per share and after the transaction beneficially owned 4,650 shares directly. The Form 4 was filed by one reporting person and was signed by an attorney-in-fact on the same date.

Positive

• Insider purchase reported: 4,650 shares acquired on 09/18/2025
• Transparent disclosure: Transaction coded as a purchase (P) and filed on a single Form 4

Negative

• None.

Insights

Financial Analyst

TL;DR: Insider purchase of 4,650 shares at $21.28 signals management buying stock, a potentially supportive ownership action.

The filing documents a straightforward purchase transaction coded "P" for 4,650 shares resulting in direct beneficial ownership of 4,650 shares. For a public company, insider purchases can be interpreted as alignment with shareholder value, though the filing does not disclose the size of total insider holdings or context about frequency of purchases. This is a routine Section 16 disclosure without further material disclosures.

Corporate Governance Expert

TL;DR: Reporting is compliant and timely; purchase was executed and reported on 09/18/2025 with a manual signature via attorney-in-fact.

The Form 4 identifies Scott Lang as both President and CEO and a director, and shows a direct acquisition of 4,650 shares at $21.28. The form indicates a single reporting person and includes the required signature executed by an attorney-in-fact. There are no amendments, derivative transactions, or indicia of complex arrangements disclosed in this filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Lang Scott A.

(Last) (First) (Middle)

3 GARRET MOUNTAIN PLAZA

SUITE 401

(Street)

WOODLAND PARK NJ 07424

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Anterix Inc. [ ATEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
09/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/18/2025		P		4,650	A	$21.28	4,650	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	s/ Gena L. Ashe, Attorney-in-Fact	09/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Anterix Inc. (ATEX) insider Scott Lang report on Form 4?

He reported a purchase of 4,650 shares of Common Stock on 09/18/2025 at a price of $21.28 per share and now directly beneficially owns 4,650 shares.

What is the relationship of the reporting person to ATEX?

The reporting person, Lang Scott A., is listed as President and CEO and a Director of Anterix Inc.

How was the Form 4 filed and signed?

The Form 4 was filed by one reporting person and bears a signature executed by an attorney-in-fact (s/ Gena L. Ashe) dated 09/18/2025.

Does the filing show any derivative transactions or disposals?

No. Table II for derivative securities is blank and the filing shows only a non-derivative purchase of common stock.

What price was paid and what is the post-transaction ownership reported?

The reported purchase price was $21.28 per share and the reporting person beneficially owned 4,650 shares following the transaction.